1. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial

   CARMELINA Investigators, 1-Jan-2019, In : JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 321, 1, p. 69-79 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer

   De Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., Colombo, A., Fyles, A., Baron, M. H., Jurgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Kolodziej, I., Carinelli, S., Lutgens, L. C. H. W., Smit, V. T. H. B. M., Singh, N., Nout, R. A., Verhoeven-Adema, K. W., Putter, H. & Creutzberg, C. L., Apr-2018, In : Radiotherapy and Oncology. 127, p. S171-S172 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

   PORTEC Study Grp, Feb-2018, In : Annals of Oncology. 29, 2, p. 424-430 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (3) »